ISSN 1673-3770 CN 37-1437/R
JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2018, Vol. 32 ›› Issue (3): 4-9.doi: 10.6040/j.issn.1673-3770.1.2018.004
Previous Articles Next Articles
LI Huabin, LAI Yuting
CLC Number:
| [1] Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012[J]. Rhinol Suppl, 2012, 23:3 p preceding table of contents, 1-298. [2] Kato A. Immunopathology of chronic rhinosinusitis[J]. Allergol Int, 2015, 64(2):121-130. [3] Steinke JW, Borish L. Chronic rhinosinusitis phenotypes[J]. Ann Allergy Asthma Immunol, 2016, 117(3):234-240. [4] Cho SW, Kim DW, Kim JW, et al. Classification of chronic rhinosinusitis according to a nasal polyp and tissue eosinophilia: limitation of current classification system for Asian population[J]. Asia Pac Allergy, 2017, 7(3):121-130. [5] Wang X, Zhang N, Bo M, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in europe, asia, and oceania[J]. J Allergy Clin Immunol, 2016, 138(5):1344-1353. [6] Maxfield AZ, Landegger LD, Brook CD, et al. Periostin as a biomarker for nasal polyps in chronic rhinosinusitis[J]. Otolaryngol Head Neck Surg, 2018, 158(1):181-186. [7] Jonstam K, Westman M, Holtappels G, et al. Serum periostin, ige, and se-ige can be used as biomarkers to identify moderate to severe chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immun, 2017, 140(6):1705-1708. [8] Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators[J]. Allergy, 2006, 61(11):1280-1289. [9] Van Crombruggen K, Zhang N, Gevaert P, et al. Pathogenesis of chronic rhinosinusitis: inflammation[J]. J Allergy Clin Immunol, 2011, 128(4):728-732. [10] Payne SC, Early SB, Huyett P, et al. Evidence for distinct histologic profile of nasal polyps with and without eosinophilia[J]. Laryngoscope, 2011, 121(10):2262-2267. [11] Van Bruaene N, Derycke L, Perez-Novo CA, et al. Tgf-beta signaling and collagen deposition in chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2009, 124(2):253-259. [12] Takabayashi T, Kato A, Peters AT, et al. Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression[J]. Am J Respir Crit Care Med, 2013, 187(1):49-57. [13] Kato A. Immunopathology of chronic rhinosinusitis[J]. Allergol Int, 2015, 64(2):121-130. [14] Klimek L, Koennecke M, Mullol J, et al. A possible role of stem cells in nasal polyposis[J]. Allergy, 2017, 72(12):1868-1873. [15] Yu XM, Li CW, Chao SS, et al. Reduced growth and proliferation dynamics of nasal epithelial stem/progenitor cells in nasal polyps in vitro[J]. Sci Rep, 2014, 4:4619. DOI:10.1038/srep04619. [16] Pezato R, de Almeida DC, Bezerra TF, et al. Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment[J]. Mediators Inflamm, 2014, 2014:583409. DOI:10.1155/2014/583409. [17] Cho KS, Kim YW, Kang MJ, et al. Immunomodulatory effect of mesenchymal stem cells on T lymphocyte and cytokine expression in nasal polyps[J]. Otolaryngol Head Neck Surg, 2014, 150(6):1062-1070. [18] Ho J, Bailey M, Zaunders J, et al. Group 2 innate lymphoid cells(ilc2s)are increased in chronic rhinosinusitis with nasal polyps or eosinophilia[J]. Clin Exp Allergy, 2015, 45(2):394-403. [19] Lam M, Hull L, Imrie A, et al. Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis[J]. Am J Rhinol Allergy, 2015, 29(3):175-181. [20] Shin HW, Kim DK, Park MH, et al. Il-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2015, 135(6):1476-1485. [21] Bachert C, Gevaert E. Advances in rhinitis and rhinosinusitis in 2015[J]. J Allergy Clin Immunol, 2016, 138(5):1277-1283. [22] Mullol J, Obando A, Pujols L, et al. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits[J]. Immunol Allergy Clin North Am, 2009, 29(4):657-668. [23] Schlosser RJ, Bolger WE. Nasal cerebrospinal fluid leaks: chritical review and surgical considerations[J]. Laryngoscope, 2004, 114(2):255-265. [24] Koay B, Bates G, Elston J. Endoscopic orbital decompression for dysthyroid eye disease[J]. J Laryngol Otol, 1997, 111(10):946-949. [25] Wigand ME, Hosemann WG. Results of endoscopic surgery of the paranasal sinuses and anterior skull base[J]. J Otolaryngol, 1991, 20(6):385-390. [26] Bachert C, Akdis CA. Phenotypes and emerging endotypes of chronic rhinosinusitis[J]. J Allergy Clin Immunol Pract, 2016, 4(4):621-628. [27] Stevens WW, Ocampo CJ, Berdnikovs S, et al. Cytokines in chronic rhinosinusitis role in eosinophilia and aspirin-exacerbated respiratory disease[J]. Am J Respir Crit Care Med, 2015, 192(6):682-694. [28] Yoo F, Ference EH, Kuan EC, et al. Evaluation of patient nasal saline irrigation practices following endoscopic sinus surgery[J]. Int Forum Allergy Rhinol, 2018, 8(1):32-40. [29] Rezaeian A. Outcome of spray cryotherapy plus functional endoscopic sinus surgery on management of healing in nasal polyposis[J] Am J Otolaryngol, 2018, 39(1):10-13. [30] Chen JN, Wang X, Chen LZ, et al. Influence of hyaluronan nasal dressing on clinical outcome after endoscopic sinus surgery: a systematic review and meta-analysis[J]. Am J Rhinol Allergy, 2017, 31(4):256-259. [31] Lou H, Meng Y, Piao Y, et al. Predictive significance of tissue eosinophilia for nasal polyp recurrence in the chinese population[J]. Am J Rhinol Allergy, 2015, 29(5):350-356. [32] Van Zele T, Holtappels G, Gevaert P, et al. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps[J]. Am J Rhinol Allergy, 2014, 28(3):192-198. [33] Ramakrishnan VR, Hauser LJ, Feazel LM, et al. Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome[J]. J Allergy Clin Immunol, 2015, 136(2):334-342. [34] Kennedy JL, Hubbard MA, Huyett P, et al. Sino-nasal outcome test(snot-22): a predictor of postsurgical improvement in patients with chronic sinusitis[J]. Ann Allergy Asthma Immunol, 2013, 111(4):246-251. [35] Dautremont JF, Rudmik L. When are we operating for chronic rhinosinusitis? A systematic review of maximal medical therapy protocols prior to endoscopic sinus surgery[J]. Int Forum Allergy Rhinol, 2015, 5(12):1095-1103. [36] Sylvester DC, Carr S, Nix P. Maximal medical therapy for chronic rhinosinusitis: a survey of otolaryngology consultants in the united kingdom[J]. Int Forum Allergy Rhinol, 2013, 3(2):129-132. [37] Schwartz JS, Tajudeen BA, Cohen NA. Medical management of chronic rhinosinusitis-an update[J]. Expert Rev Clin Pharmacol, 2016, 9(5):695-704. [38] Orlandi RR, Kingdom TT, Hwang PH, et al. International consensus statement on allergy and rhinology: rhinosinusitis[J]. Int Forum Allergy Rhinol, 2016, 6(Suppl 1):22-209. DOI:10.1002/air.21695. [39] Chong LY, Head K, Hopkins C, et al. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis[J]. Cochrane Database Syst Rev, 2016, 4. DOI: 10. 1002/14651858. [40] Head K, Chong LY, Hopkins C, et al. Short-course oral steroids alone for chronic rhinosinusitis[J]. Cochrane Database Syst Rev, 2016, 4. DOI: 10. 1002/14651858. [41] Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids[J]. Otolaryngol Clin North Am, 2010, 43(4):753-768. [42] Soler ZM, Oyer SL, Kern RC, et al. Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendations[J]. Int Forum Allergy Rhinol, 2013, 3(1):31-47. [43] Oakley GM, Harvey RJ, Lund VJ. The role of macrolides in chronic rhinosinusitis(crssnp and crswnp)[J]. Curr Allergy Asthma Rep, 2017, 17(5):30. [44] Lee JT, Chiu AG. Topical anti-infective sinonasal irrigations: update and literature review[J]. Am J Rhinol Allergy, 2014, 28(1):29-38. [45] Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis:a randomized clinical trial[J]. JAMA, 2016, 315(5):469-479. [46] Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma[J]. J Allergy Clin Immunol, 2013, 131(1):110-116. [47] Gevaert P, Lang-Loidolt D, Lackner A, et al. Nasal il-5 levels determine the response to anti-il-5 treatment in patients with nasal polyps[J]. J Allergy Clin Immunol, 2006, 118(5):1133-1141. [48] Sivasubramaniam R, Harvey RJ. How to assess, control, and manage uncontrolled crs/nasal polyp patients[J]. Curr Allergy Asthma Rep, 2017, 17(9):58. |
| [1] | SONG Xiaoyu, ZHANG Yu, LI Chenglin, SONG Xicheng. Enhanced recovery after surgery for the treatment of chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(5): 9-12. |
| [2] | HUANG Yuan, BA Luo, LI Bo, YU Wenxing, YANG Fangli, DU Jintao. Transcription factor NKX2-1 regulates eosinophilic inflammation in chronic rhinosinusitis with nasal polyps [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 17-23. |
| [3] | CHEN Wangxing, ZHAO Xue, LIU Yan, LIU Yue, JIN Chunshun. Psychological status of patients with deviated nasal septum or chronic sinusitis with nasal polyps [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 24-27. |
| [4] | Effect of short-term glucocorticoid inhalation on nasal symptoms and adrenocortical function in patients with eosinophilic chronic sinusitis accompanied by nasal polyps. Effect of short-term glucocorticoid inhalation on nasal symptoms and adrenocortical function in patients with eosinophilic chronic sinusitis accompanied by nasal polyps [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 28-31. |
| [5] | YU Qianqian, GUAN Ge, ZHANG Niankai, LI Na, WEN Junfeng, LIU Tingting, LIAN Yuanyuan. Characteristics of respiratory epithelial adenomatoid hamartomas in the nasal olfactory cleft on computed tomography [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 76-81. |
| [6] | LI Hongmei, WANG Lan, GAO Zhaohui, WANG Ying, XUE Jinmei. The expression and significance of p-ERK2/ ERK2 in nasal polyps [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 42-46. |
| [7] | ZHANG Jie, GONG Qi. Clinical significance of eosinophils and neutrophils in blood and allergic reaction in patients with chronic rhinosinusitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 54-57. |
| [8] | GAN Bin, ZHANG Yongju, XU Anting. BRF2 in the pathogenesis of chronic rhinosinusitis with nasal polyps [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 47-53. |
| [9] | ZHI Lili, SONG Daoliang. Expressions of eosinophils and IL5 in antrochoanal polyps and nasal polyps. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 43-46. |
| [10] | LUN Jie, ZHANG Ya′nan. Analysis on the factors related to the recurrence of chronic rhinosinusitis with nasal polyps. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 80-83. |
| [11] | SHI Li, ZHAO Li, ZHANG Hongping. Long-term anti-inflammatory treatment of allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 9-12. |
| [12] | WANG Haipeng, XU Huijuan, ZHANG Xiufang, WANG Huizhong, LI Yanzhong. The application of Sinus Jel in adult patients of nasal polyps with sleep-disordered breathing. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(5): 58-60. |
| [13] | SU Yi, XIE Jinghua, PAN Xiaoli, ZENG Guoqing. Efficacy and associated factors of endoscopic sinus surgery on patients with chronic rhinosinusitis with or without nasal polyps. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 86-89. |
| [14] | LI Houjie, QU Qian, XU Shicai, LIU Lingbing, ZHANG Yongchao, WANG Xuzeng, LIU Lei. Clinical experience on the treatment of antrochoanal polyp under nasal endoscopy by expand road of the combined middle-inferior meatus. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(2): 62-64. |
| [15] | ZHANG Jian, LU Xiaoqing, WU Jian.. Differentially expressed proteins between nasal polyps and normal nasal mucosa by the iTRAQ technology. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(1): 5-8. |
|
||